Evidence map›Paper›PMID 30186226›Full record

ArticleFrontiers in neurology2018

Brian D Robertson, Abdullah S Al Jaja, Alex A MacDonald, Nole M Hiebert, Ruzbeh Tamjeedi, Ken N Seergobin, Ute I Schwarz, Richard B Kim, Penny A MacDonald

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Brian D RobertsonSchulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada.
Abdullah S Al JajaBrain and Mind Institute, University of Western Ontario, London, ON, Canada.
Alex A MacDonaldDepartment of Medicine, Undergraduate Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Nole M HiebertBrain and Mind Institute, University of Western Ontario, London, ON, Canada.
Ruzbeh TamjeediFaculty of Law, University of Ottawa, Ottawa, ON, Canada.
Ken N SeergobinBrain and Mind Institute, University of Western Ontario, London, ON, Canada.
Ute I SchwarzDepartment of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada.
Richard B KimDepartment of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada.
Penny A MacDonaldBrain and Mind Institute, University of Western Ontario, London, ON, Canada.
Western University · CAUniversity of Ottawa · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Parkinson's disease (PD), cognitive functions mediated by brain regions innervated by ventral tegmental area (VTA) worsen with dopamine replacement therapy, whereas processes relying on regions innervated by the substantia nigra pars compacta (SNc) improve. The

Indexed as

dopamineencodingoverdoseParkinson's diseasepolymorphismSLC6A3

Identifiers

PMID30186226
PMCPMC6110885
OpenAlexW2888028893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.